MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Connectomic DBS informed multifocal transcranial direct current stimulation (tDCS) in Parkinson’s Disease: a crossover double blinded study

    L L. Goede, S. Oxenford, D. Kroneberg, G M. Meyer, N. Rajamani, C. Neudorfer, P. Krause, R. Lofredi, M D. Fox, A A. Kühn, A. Horn (Berlin, Germany)

    Objective: To determine if non-invasive neuromodulation of a network previously identified through invasive neuromodulation could improve motor symptoms in Parkinson's disease (PD). Background: A recent…
  • 2023 International Congress

    Cortical mean diffusivity changes in Parkinson’s disease with probable RBD

    J. Pardo, V. Montal, A. Campabadal, J. Oltra, C. Uribe, I. Roura, MJ. Martí, Y. Compta, A. Iranzo, J. Fortea, C. Junqué, B. Segura (Barcelona, Spain)

    Objective: To investigate cortical mean diffusivity (cMD) as a sensitive measure to identify subtle microstructural cortical changes in Parkinson’s disease (PD) patients with probable REM…
  • 2023 International Congress

    Electronic Development of the MDS-UPDRS and MDS-NMS: Process and User Feedback

    R. Fuller, M. Monje, A. Sanchez Ferro, T. Mestre, L. Chahine, K. Dujardin, C. Fitzer-Attas, S. Groppa, S. Perez-Lloret, T. Turner, J. Youn, P. Martinez-Martin, G. Stebbins (Princeton, USA)

    Objective: To describe the processes for development and obtaining user feedback of the electronic versions of the MDS Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) and…
  • 2023 International Congress

    Physical exercise as a promising option for treating fatigue in Parkinson’s disease? Results of a systematic review and meta-analysis of non-pharmacological interventions

    A. Folkerts, J. Nielsen, R. Gollan, A. Lansu, D. Solfronk, I. Monsef, N. Skoetz, K. Zeuner, E. Kalbe (Cologne, Germany)

    Objective: To give an update on randomized controlled trials (RCT) including non-pharmacological intervention approaches that examine effects on fatigue in people with Parkinson’s disease (PD).…
  • 2023 International Congress

    Subject-specific investigation of pathways underlying therapeutic outcomes of deep brain stimulation for Essential Tremor

    R. Butler, M. Blumenfeld, A. Brinda, M. Bryants, D. Sullivan, S. Pandey, T. Palnitkar, R. Patriat, J. Vitek, L. Schrock, K. Gagesch, K. Domingo, T. Orcutt, N. Harel, J. Matsumoto, S. Cooper, M. Johnson (Minneapolis, USA)

    Objective: To relate subject-specific pathway activation models of motor thalamic deep brain stimulation (DBS) to clinical outcomes in patients with Essential Tremor (ET). Background: Computational…
  • 2023 International Congress

    The Dystonic Drive – A Systematic Review on Coherence Analysis in Dystonia

    S. Lagerweij, M. Smit, L. Centen, M. van Egmond, JW. Elting, M. Tijssen (Groningen, Netherlands)

    Objective: To perform a systematic review on coherence analysis in dystonia. We focus on different modalities and describe the relation of abnormal coherent frequency bands…
  • 2023 International Congress

    Remote monitoring of physical activity in Progressive Supranuclear Palsy (PSP) using wearable sensors

    AM. Wills, R. Mishra, M. Sharma, AJ. Hall, J. Casado, R. Cole, A. Vaziri, A. Pantelyat (Boston, USA)

    Objective: To remotely monitor physical activity in people with PSP and to correlate it with disease progression on the modified PSP Rating Scale (mPSPRS-21). Background:…
  • 2023 International Congress

    Disease progression of spinocerebellar ataxia types 1, 2, 3, and 6 before and after ataxia onset: a joint analysis of two longitudinal cohort studies

    H. Jacobi, T. Schaprian, M. Schmid, T. Klockgether (Heidelberg, Germany)

    Objective: The aim was to model the evolution of ataxia and neurological symptoms in SCA1, SCA2, SCA3, and SCA6 over the entire disease span and…
  • 2023 International Congress

    Application of multi-parametric diffusion MRI in detecting visual disturbances in advanced Parkinson’s disease population

    K. Shivok, I. Ailes, M. Syed, I. Shelley, A. Alhussein, I. Fayed, T-W. Liang, C. Wu, A. Sharan, F. Mohamed, R. Sergott, L. Krisa, M. Alizadeh (Philadelphia, USA)

    Objective: We aimed to identify differences in multi-parametric diffusion indices (DTI, NODDI, and DKI) between Parkinson’s disease patients with visual disturbances and those without. Background:…
  • 2023 International Congress

    Autosomal dominant Parkinson’s disease caused by SNCA p.E46K variant in family with Russian ancestry: A case report

    K. Senkevich, I. Miliukhina, A. Zhuravlev, M. Shumilova, M. Beletskaia, A. Tyurin, M. Grunina, A. Rybakov, J. Ahmad, F. Asayesh, A. Timofeeva, Z. Gan-Or, A. Emelyanov, S. Pchelina (Montreal, Canada)

    Objective: To report a family with autosomal dominant Parkinson’s disease (PD) with SNCA p.E46K variant. Background: Alpha-synuclein, encoded by SNCA, is a part of Lewy…
  • « Previous Page
  • 1
  • …
  • 179
  • 180
  • 181
  • 182
  • 183
  • …
  • 186
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley